Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Journal of Clinical Lipidology|April 21, 2019
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiencyEmile Zakiev, Fabiana Rached, Marie Lhomme, et al.
Communications Engineering|June 11, 2025
The effect of device geometry on the performance of a wave energy converterEmma C Edwards, Craig Whitlam, John Chapman, et al.
The New England Journal of Medicine|November 17, 2011
Effect of two intensive statin regimens on progression of coronary diseaseStephen J Nicholls, Christie M Ballantyne, Philip J Barter, et al.
Human Molecular Genetics|July 29, 2005
Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS StudyEric Frisdal, Anke H E M Klerkx, Wilfried Le Goff, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 3, 2012
Bcl-x inactivation in macrophages accelerates progression of advanced atherosclerotic lesions in Apoe(-/-) miceAndrew I U Shearn, Virginie Deswaerte, Emmanuel L Gautier, et al.
Circulation|September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyRishi Puri, Steven E Nissen, Peter Libby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 13, 2014
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatinRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Journal of Lipid Research|July 3, 2008
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasmaClaes Bergmark, Asheesh Dewan, Alexina Orsoni, et al.
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Journal of Clinical Lipidology|April 21, 2019
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiencyEmile Zakiev, Fabiana Rached, Marie Lhomme, et al.
Communications Engineering|June 11, 2025
The effect of device geometry on the performance of a wave energy converterEmma C Edwards, Craig Whitlam, John Chapman, et al.
The New England Journal of Medicine|November 17, 2011
Effect of two intensive statin regimens on progression of coronary diseaseStephen J Nicholls, Christie M Ballantyne, Philip J Barter, et al.
Human Molecular Genetics|July 29, 2005
Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS StudyEric Frisdal, Anke H E M Klerkx, Wilfried Le Goff, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 3, 2012
Bcl-x inactivation in macrophages accelerates progression of advanced atherosclerotic lesions in Apoe(-/-) miceAndrew I U Shearn, Virginie Deswaerte, Emmanuel L Gautier, et al.
Circulation|September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyRishi Puri, Steven E Nissen, Peter Libby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 13, 2014
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatinRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Journal of Lipid Research|July 3, 2008
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasmaClaes Bergmark, Asheesh Dewan, Alexina Orsoni, et al.
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Pageof 32